Haut.AI Funding: How Much Did They Raise & Key Investors

How Much Did Haut.AI Raise?
Funding & Key Investors

Haut.AI has successfully secured a significant capital injection, marking a pivotal moment in its corporate evolution. With a total funding accumulation of $2.1M, the company is well-positioned to scale its operations within the competitive beauty-tech landscape. The most recent strategic investment of $2.1M underscores the market confidence in the firm's proprietary computer vision and machine learning capabilities, which are currently reshaping how skincare and pharmaceutical entities leverage data-driven insights.

This influx of financing serves as a catalyst for the company to expand its technological footprint, moving beyond its initial development phase into a period of aggressive market penetration and product refinement.

What is Haut.AI?

Haut.AI

Software

Healthcare Software

Business Intelligence (BI) Software

Based in Estonia, Haut.AI operates a sophisticated SaaS platform that bridges the gap between advanced computer vision and the skincare industry. By utilizing algorithms trained on over one million facial and skin images, the company provides a robust API-driven infrastructure that allows clients to manage, store, and analyze complex dermatological data. The platform's core functionality includes tracking skin dynamics, generating product effect simulations, and delivering personalized lifestyle recommendations. This technological stack is essential for modern beauty brands and pharmaceutical companies seeking to integrate evidence-based AI into their consumer-facing digital tools and research pipelines.

How much funding has Haut.AI raised?

Haut.AI has raised a total of $2.1M across 1 funding round:

2023

Angel/Seed

$2.1M

Angel/Seed (2023): $2.1M with participation from Grupo Boticario and LongeVC

Key Investors in Haut.AI

Grupo Boticario

A global cosmetics enterprise with a portfolio of nine beauty brands, focusing on integrated beauty ecosystems and sustainable innovation.

LongeVC

A venture capital firm specializing in early-stage biotech and longevity innovations, supporting breakthroughs in personalized medicine and advanced diagnostics.

What's next for Haut.AI?

With the recent capital infusion, Haut.AI is expected to prioritize the expansion of its algorithmic capabilities and the broadening of its API ecosystem. The strategic focus will likely shift toward deepening partnerships with global cosmetic conglomerates and pharmaceutical research firms, aiming to standardize the use of AI in skin health diagnostics. As the company matures, the integration of more granular skin parameters and the enhancement of its recommendation engines will be critical to maintaining its competitive advantage. Investors are closely watching how the firm leverages this backing to transition from a specialized technology provider to an indispensable component of the global beauty and health-tech supply chain.

See full Haut.AI company page

See More Financial Insights